Symbol
|
RMXLTQ | LXSWLK | KQKRCH | AOIBKB | UVSLTQ | KRPRCH | Z05RUZ | KMQZDU | KMUUDU | RMAI6V | ATLBKB | CPWCBL | KNJPDU | KNIWDU | KNIYDU | KNKUDU | KNOIDU | KNNMDU | CROCBL | AAKRSQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Name | Callable Multi Barrier Reverse Convertible | LUKB Autocallable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible with European Knock-In | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Multi Defender Vonti | Barrier Reverse Convertible | Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Barrier Reverse Convertible |
Underlying
|
Compagnie Financière Richemont SA / Givaudan / Lonza Group N / Nestlé S.A. | Logitech International SA / Lonza Group N / Sika AG / Straumann Hldg. AG | Lonza Group N / Novartis Sandoz Basket / Roche AG | Alcon / Lonza Group N / Novartis Sandoz Basket / Roche AG | BASF SE / Bayer AG / Lonza Group N / Sika AG | LafargeHolcim Ltd. / Lonza Group N / Stadler Rail AG | Lonza Group N / Sonova Hldg. AG / Straumann Hldg. AG | Idorsia AG / Lonza Group N / Sonova Hldg. AG | Alcon / Lonza Group N / Roche AG | ABB N / Givaudan / Lonza Group N / Sika AG | Lonza Group N / Novartis Sandoz Basket / Roche AG | BASF SE / Bayer AG / Lonza Group N / Sika AG | Julius Baer Group / Lonza Group N / Swatch Group I | Geberit AG / Lonza Group N / Sika AG | ABB N / Givaudan / Lonza Group N / Swatch Group I | Clariant / Lonza / Sika | BASF SE / Bayer AG / Clariant AG / Lonza Group N | Lonza Group N / Novartis Sandoz Basket / Roche AG | BASF SE / Bayer AG / Givaudan / Lonza Group N | Ems-Chemie Hldg. AG / Lonza Group N / Novartis Sandoz Basket / Roche AG / Sika AG |
Issuer
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Date of maturity
|
26.08.2024 | 01.10.2024 | 12.08.2024 | 29.07.2024 | 19.08.2024 | 26.08.2024 | 03.03.2025 | 30.09.2024 | 21.10.2024 | 10.11.2025 | 16.12.2024 | 16.12.2024 | 18.07.2024 | 18.07.2024 | 18.07.2024 | 27.01.2025 | 15.08.2024 | 15.08.2024 | 13.08.2024 | 20.08.2024 |
Bid | 69.49 | 62.08 | 101.13 | 101.54 | 50.31 | 87.74 | 99.96 | 17.040 | 99.95 | 103.50 | 100.78 | 55.03 | 99.15 | 99.10 | 99.15 | 101.40 | 41.550 | 99.50 | 47.920 | 93.19 |
Ask | 66.10 | 62.55 | 101.94 | 102.36 | - | - | 100.46 | 18.040 | 100.90 | 104.30 | 101.59 | - | 100.20 | 100.10 | 100.10 | 102.40 | 42.550 | - | - | - |